504 related articles for article (PubMed ID: 376941)
1. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
[TBL] [Abstract][Full Text] [Related]
2. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
[TBL] [Abstract][Full Text] [Related]
3. Experimental glomerulonephritis in the isolated perfused rat kidney.
Couser WG; Steinmuller DR; Stilmant MM; Salant DJ; Lowenstein LM
J Clin Invest; 1978 Dec; 62(6):1275-87. PubMed ID: 372233
[TBL] [Abstract][Full Text] [Related]
4. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
Bertani T; Remuzzi G; Poggi A; Delaini F; Sacchi G; Morassi L; Verroust P; Mecca G; Donati MB
Clin Exp Immunol; 1983 Jan; 51(1):38-44. PubMed ID: 6339125
[TBL] [Abstract][Full Text] [Related]
5. Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein.
Couser WG; Stilmant MM; Darby C
Lab Invest; 1976 Jan; 34(1):23-30. PubMed ID: 1246122
[TBL] [Abstract][Full Text] [Related]
6. The effects of aminonucleoside of puromycin and nephrotoxic serum on subepithelial immune-deposit formation in passive Heymann nephritis.
Couser WG; Salant DJ; Stilmant MM; Arbeit LA; Darby C; Sliogeris VG
J Lab Clin Med; 1979 Dec; 94(6):917-32. PubMed ID: 501213
[No Abstract] [Full Text] [Related]
7. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
Natori Y; Hayakawa I; Shibata S
Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
9. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.
Salant DJ; Darby C; Couser WG
J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of a highly purified brush border membrane preparation in Heymann nephritis.
Chant S; Katz A; Silverman M
J Clin Lab Immunol; 1980 Nov; 4(3):133-40. PubMed ID: 6451709
[TBL] [Abstract][Full Text] [Related]
11. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
Bhan AK; Schneeberger EE; Baird LG; Collins AB; Kamata K; Bradford D; Erikson ME; McCluskey RT
Lab Invest; 1985 Oct; 53(4):421-32. PubMed ID: 3900581
[TBL] [Abstract][Full Text] [Related]
12. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat.
Weening JJ; Grond J; Hoedemaeker PJ
Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777
[TBL] [Abstract][Full Text] [Related]
13. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
Hoyer JR; Mauer SM; Michael AF
J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
[TBL] [Abstract][Full Text] [Related]
14. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat.
Adler S; Baker P; Pritzl P; Couser WG
J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891
[TBL] [Abstract][Full Text] [Related]
15. Progressive passive Heymann nephritis in the rat.
Barabas AZ; Boyd N; Cornish J; Lannigan R
Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of circulating autoantibody levels in the rat with established progressive passive Heymann nephritis.
Barabas AZ; Cornish J; Lannigan R
Clin Exp Immunol; 1986 Jul; 65(1):34-41. PubMed ID: 3539426
[TBL] [Abstract][Full Text] [Related]
17. Autologous immune complex nephritis in rats. Influence of modification of mononuclear phagocyte system function.
Abrass CK
Lab Invest; 1984 Aug; 51(2):162-71. PubMed ID: 6611451
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
[TBL] [Abstract][Full Text] [Related]
19. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
[TBL] [Abstract][Full Text] [Related]
20. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
